22 TWENTYFOURSEVENBIOPHARMA Issue 2 / June 2025 BIO INTERNATIONAL CONVENTION What new products or innovations is your company showcasing at BIO 2025 this year? At BIO 2025, Tjoapack is showcasing its expanded capabilities in injectable packaging and cold chain storage, which have been strategically upgraded in both the United States and the Netherlands. Key innovations include: - A fully automated, high-speed vial packaging line in Clinton, Tennessee, capable of processing up to 20 million vials per year with integrated labeling, cartoning, and serialization. - A semi-automated packaging line for autoinjectors, offering full traceability and labeling, also based in Clinton. - An advanced pre-filled syringe (PFS) packaging line in Etten-Leur, the Netherlands, now fully operational and commercially validated, supporting complex assembly and customization needs such as safety device application and ancillary component insertion. These upgrades enable Tjoapack to support a broader range of primary container formats, including vials, ampoules, syringes, and autoinjectors. What are you hoping to achieve from the event? Tjoapack aims to connect with pharmaceutical and biotech companies that are seeking a contract packaging partner with scalable, GMP-compliant infrastructure for biologics and sterile injectables. The company is highlighting its ability to deliver: - Faster turnaround times - Increased operational flexibility - Expanded support for complex, patient-centric delivery systems such as pre-filled syringes and auto-injectors The event serves as a platform to demonstrate how these investments align with client needs across North America and Europe. How does your company stay ahead of industry trends and developments in the pharmaceutical sector? PETER BELDEN President of the US facility Tjoapack
RkJQdWJsaXNoZXIy MjY2OTA4MA==